stocksGLAXO
GLAXO

Glaxosmithkline Pharmaceuticals Ltd.

2,928.20-29.6 (-1.00%)
8 Sep, 12:00 AM

Annual Reports and Financial Documents

Glaxosmithkline Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Glaxosmithkline Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Newspaper Publication2 Sept 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    As per attachment
  2. Postal Ballot1 Sept 2026
    Corrigendum To The Notice Of Postal Ballot Dated August 3, 2026
    As per attachment
  3. General26 Aug 2026
    Volume Movement Letter
    As per attachment
  4. General19 Aug 2026
    Disclosure Under Regulation 30
    As per attachment
  5. Newspaper Publication14 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    As per attachment
  6. Postal Ballot13 Aug 2026
    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
    As per attachment
  7. Analyst / Investor Meet6 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Transcript
  8. General6 Aug 2026
    Disclosure Under Regulation 30
    IT Refund of Rs 52 crores
  9. Analyst / Investor Meet5 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    As per attachment
  10. Newspaper Publication4 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    As per attachment
  11. Analyst / Investor Meet3 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    As per attachment
  12. Change in Management3 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Reappointment of Managing Director
  13. Resignation of Director3 Aug 2026
    Announcement under Regulation 30 (LODR)-Resignation of Director
    As per attachment
  14. Change in Directorate3 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    As per attachment
  15. Press Release / Media Release3 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    As per attachment
  16. Analyst / Investor Meet3 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Presentation
  17. Outcome of Board Meeting3 Aug 2026
    Board Meeting Outcome for Outcome Of Meeting
    Outcome of Meeting
  18. Analyst / Investor Meet21 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    As per attachment
  19. Board Meeting21 Jul 2026
    Board Meeting Intimation for Approve And Take On Record The Un-Audited Financial Results For The First Quarter Ended 30Th June 2026.
    Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve approve and ....
  20. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    As per attachment

Frequently Asked Questions

Where can I download the annual report of Glaxosmithkline Pharmaceuticals Ltd.?
Annual reports of Glaxosmithkline Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Glaxosmithkline Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Glaxosmithkline Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Glaxosmithkline Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Glaxosmithkline Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Glaxosmithkline Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Glaxosmithkline Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Glaxosmithkline Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Glaxosmithkline Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Glaxosmithkline Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Glaxosmithkline Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Glaxosmithkline Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Glaxosmithkline Pharmaceuticals Ltd. is INE159A01016. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Glaxosmithkline Pharmaceuticals Ltd. listed?
Glaxosmithkline Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is GLAXO and the BSE code is -.
Where can I find the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Glaxosmithkline Pharmaceuticals Ltd. on Sharpely?
Share price data for Glaxosmithkline Pharmaceuticals Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.